48-621MAG MILLIPLEX MAP DNA Damage/Genotoxicity Magnetic Bead Panel - Cell Signaling Multiplex Assay

96-well plate  
Zjišťuji cenu...
Cenu nelze zjistit
Minimum Quantity needs to be mulitiple of
S dokončenou objednávkou Další informace
Ušetřili jste ()
Vyžádat nacenění
Omezená dostupnostOmezená dostupnost
Na skladě 
Dostupné omezené množství
Dostupnost bude potvrzena
    Remaining : Will advise
      Remaining : Will advise
      Bude poskytnuto
      Kontaktujte Zákaznický servis
      Contact Customer Service


      Kontaktujte Zákaznický servis

      Klikněte pro vytištění této stránky


      Replacement Information

      Tabulka spec. kláve

      Analytes AvailableSpecies ReactivityKey ApplicationsDetection Methods
      ATR (Total), Chk1 (Ser345), Chk2 (Thr68), H2A.X (Ser139), MDM2 (total), p21 (Total), p53 (Ser15) H, M, R Mplex Luminex xMAP
      Catalogue Number48-621MAG
      Trade Name
      DescriptionMILLIPLEX MAP DNA Damage/Genotoxicity Magnetic Bead Panel - Cell Signaling Multiplex Assay
      OverviewThe MILLIPLEX® MAP 7-plex DNA Damage/Genotoxicity Magnetic Bead Kit (Cat. No. 48-621MAG) is a premixed kit to be used for the simultaneous quantification of the following 7 analytes in cell lysates:

      • ATR (total)
      • Chk1 (Ser345)
      • Chk2 (Thr68)
      • H2A.X (Ser139)
      • MDM2 (total)
      • p21 (total)
      • p53 (Ser15)
      Product Information
      Detection methodLuminex xMAP
      Panel TypeCell Signaling
      ApplicationIntracellular Bead-Based Multiplex Assays using the Luminex technology enables the simultaneous relative quantitation of multiple phosphorylation and total pathway proteins in tissue and cell lysate samples. Compare Multiplexing results to those of Western blotting.
      Key Applications
      • Multiplexing
      Application Notes• An overnight (4°C) incubation is recommended for best results.
      • This assay requires 25 µL diluted cell lysate per well.
      • This kit must be run using Assay Buffer 1 (provided).
      • The suggested working range of protein concentration for the assay is 1 to 25 µg of total protein/well (25 μL/well at 40 to 1,000 µg/mL).
      Biological Information
      SpecificityCross-reactivity between the antibodies and any of the other analytes in this panel is non-detectable or negligible.
      Species Reactivity
      • Human
      • Mouse
      • Rat
      Analytes Available
      • ATR (Total)
      • Chk1 (Ser345)
      • Chk2 (Thr68)
      • H2A.X (Ser139)
      • MDM2 (total)
      • p21 (Total)
      • p53 (Ser15)
      Assay PanelEverything you need in a single kit.
      Physicochemical Information
      Materials Information
      Toxicological Information
      Safety Information according to GHS
      Safety Information
      Product Usage Statements
      Usage Statement
      • Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.
      Storage and Shipping Information
      Storage ConditionsRecommended storage for kit components is 2 - 8°C.
      Packaging Information
      Material Size96-well plate
      Transport Information
      Supplemental Information



      7-plex DNA Damage/ Genotoxicity Magnetic Bead Kit 96-well Plate



      Safety Data Sheet (SDS) 


      A closer look at immunoassay platforms. Beyond fit for purpse. Bring your biomarkers to life with Merck Millipore Immunoassay Platform Solutions.
      Custom Immunoassay Menu of Services
      The Power of Biomarker Analysis

      Technical Info

      96 well Template 2 Up
      96 well Template Single
      Exploring DNA Damage/Genotoxicity Using the MILLIPLEX® MAP 7-plex DNA Damage/Genotoxicity Kit

      Data Sheet

      Full Service Custom-built Assays


      MILLIPLEX MAP: Exercise, Signaling, and Your Brain
      Toxicology in drug discovery and development: Biomarkers and model organisms